CAU
ASPN icon

Caxton Associates (UK)’s Aspen Aerogels ASPN Stock Holding History

Caxton Associates (UK)’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,654
Closed -$95K – 769
2025
Q3 		$95K Sell
13,654
-89,518
-87% -$631K ﹤0.01% 668
2025
Q2 		$611K Buy
103,172
+55,167
+115% +$317K 0.02% 380
2025
Q1 		$307K Buy
+48,005
New +$463K 0.01% 624

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caxton Associates (UK)'s ASPN Position: Q4 2025 in Review

Caxton Associates (UK) sold out of Aspen Aerogels (ASPN) in Q4 2025, closing a stake of 13,654 shares — an estimated $95K sold.

Caxton Associates (UK) first reported a position in ASPN in Q1 2025 and held it in 3 quarters. The position peaked at $611K in Q2 2025. 183 funds tracked by Wall St. Rank hold ASPN as of Q4 2025.

  • Caxton Associates (UK) reported no remaining Aspen Aerogels position as of Q4 2025 after selling out during the quarter.
  • Caxton Associates (UK) sold 13,654 Aspen Aerogels shares in Q4 2025, an estimated $95K.
  • Caxton Associates (UK) first reported a position in Aspen Aerogels in Q1 2025 and held it in 3 quarters.
  • Caxton Associates (UK)'s Aspen Aerogels position peaked at $611K in Q2 2025.
  • 183 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2025.

Based on Caxton Associates (UK)'s 13F filing for Q4 2025, filed 13 Feb 2026.